Novanta Board Authorizes Repurchase Of Up To Addl. $200M Of Outstanding Common Shares, Adding Capacity To $31M Remaining From 2020 Board Authorization, For Total Capacity Of $231M

Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that its Board of Directors has authorized the repurchase of up to an additional $200 million of the Company's outstanding common shares, adding capacity to the $31 million remaining from its 2020 Board authorization, for a total capacity of $231 million.